Edmond de Rothschild Holding’s Alexion Pharmaceuticals ALXN Stock Holding History

Edmond de Rothschild Holding’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-350	Closed	-$55K	–	763
2020 Q4	$55K	Sell	350 -16,652	-98%	-$2.14M	﹤0.01%	559
2020 Q3	$1.95M	Buy	17,002 +2,505	+17%	+$270K	0.08%	201
2020 Q2	$1.63M	Buy	14,497 +5,600	+63%	+$595K	0.07%	201
2020 Q1	$799K	Buy	+8,897	New	+$873K	0.04%	230
2018 Q3	–	Sell	-250	Closed	-$31K	–	783
2018 Q2	$31K	Hold	250	–	–	﹤0.01%	643
2018 Q1	$28K	Hold	250	–	–	﹤0.01%	684
2017 Q4	$30K	Buy	+250	New	+$30.4K	﹤0.01%	685
2017 Q3	–	Sell	-335	Closed	-$41K	–	870
2017 Q2	$41K	Hold	335	–	–	﹤0.01%	673
2017 Q1	$41K	Hold	335	–	–	﹤0.01%	670
2016 Q4	$41K	Buy	+335	New	+$41K	﹤0.01%	673

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Edmond de Rothschild Holding's ALXN Position: Q1 2021 in Review

Edmond de Rothschild Holding sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 350 shares — an estimated $55K sold.

Edmond de Rothschild Holding first reported a position in ALXN in Q4 2016 and held it in 10 quarters. The position peaked at $1.95M in Q3 2020. 754 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

Edmond de Rothschild Holding reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Edmond de Rothschild Holding sold 350 Alexion Pharmaceuticals shares in Q1 2021, an estimated $55K.
Edmond de Rothschild Holding first reported a position in Alexion Pharmaceuticals in Q4 2016 and held it in 10 quarters.
Edmond de Rothschild Holding's Alexion Pharmaceuticals position peaked at $1.95M in Q3 2020.
754 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2021, filed 17 May 2021.